{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:33:50Z","timestamp":1786988030309,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejca.2016.10.013","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T03:45:44Z","timestamp":1479440744000},"page":"34-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Current therapy and the evolving molecular landscape of paediatric ependymoma"],"prefix":"10.1016","volume":"70","author":[{"given":"Soumen","family":"Khatua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bouffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 10","key":"10.1016\/j.ejca.2016.10.013_bib1","doi-asserted-by":"crossref","first-page":"x1","DOI":"10.1093\/neuonc\/nou327","article-title":"Alex Lemonade Stand Foundation Infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011","volume":"16","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11060-005-6753-9","article-title":"New therapeutic approaches including radiation and chemotherapy","volume":"75","author":"Merchant","year":"2005","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3171\/2008.9.JNS08117","article-title":"Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study","volume":"110","author":"McGuire","year":"2009","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2016.10.013_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000339320","article-title":"Predictors of survival among pediatric and adult ependymoma cases: a study using surveillance, epidemiology and end results data from 1973 to 2007","volume":"39","author":"Amirian","year":"2012","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ejca.2016.10.013_bib5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/path.1005","article-title":"Low incidence of SV40- like sequences in ependymal tumors","volume":"195","author":"Reuther","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2016.10.013_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3171\/2010.11.SPINE10350","article-title":"Spinal ependymomas in neurofibromatosis type 2: a retrospective analysis of 55 patients","volume":"14","author":"Plotkin","year":"2011","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.ejca.2016.10.013_bib7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ejca.2016.10.013_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00043426-199905000-00008","article-title":"A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors","volume":"21","author":"Horn","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/pbc.24996","article-title":"A retrospective analysis of recurrent intracranial ependymoma","volume":"61","author":"Antony","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejca.2016.10.013_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3346\/jkms.1996.11.5.415","article-title":"Papillary ependymoma: its differential diagnosis from choroid plexus papilloma","volume":"11","author":"Park","year":"1996","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ejca.2016.10.013_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00684931","article-title":"Oligodendroglioma-like cells (clear cells) in ependymoma","volume":"62","author":"Kawano","year":"1983","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ejca.2016.10.013_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/01913129709021312","article-title":"Tanycytic ependymoma","volume":"21","author":"Langford","year":"1997","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.ejca.2016.10.013_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF02479429","article-title":"Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas","volume":"18","author":"Suzuki","year":"2001","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.ejca.2016.10.013_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-5751-10-7","article-title":"Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts","volume":"10","author":"Ellison","year":"2011","journal-title":"J Neqat Results Biomed"},{"key":"10.1016\/j.ejca.2016.10.013_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11060-015-1955-2","article-title":"Myxopapillary ependymomas in children: imaging, treatment and outcomes","volume":"126","author":"Bandopadhayay","year":"2016","journal-title":"J Neuroncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11060-007-9411-6","article-title":"Subependymoma revisited: clinicopathological evaluation of 83 cases","volume":"85","author":"Rushing","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0360-3016(97)00893-6","article-title":"Ependymoma: results, prognostic factors and treatment recommendations","volume":"40","author":"McLaughlin","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2016.10.013_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00401-012-0981-9","article-title":"Distinct disease- risk groups in pediatric supratentorial and posterior fossa ependymomas","volume":"124","author":"Godfraind","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ejca.2016.10.013_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3171\/2010.5.PEDS09553","article-title":"Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database","volume":"6","author":"Benesch","year":"2010","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.ejca.2016.10.013_bib20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s003810050487","article-title":"The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases","volume":"16","author":"Palma","year":"2000","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ejca.2016.10.013_bib21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11060-010-0344-0","article-title":"Intracranial ependymomas treated with radiotherapy: long term results from a single institution","volume":"102","author":"Swanson","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib22","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3171\/jns.1997.86.6.0943","article-title":"Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy","volume":"86","author":"Merchant","year":"1997","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2016.10.013_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ijrobp.2007.11.058","article-title":"Intensity-modulated radiation therapy in childhood ependymoma","volume":"71","author":"Schroeder","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2016.10.013_bib24","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ijrobp.2007.11.065","article-title":"Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons","volume":"71","author":"MacDonald","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2016.10.013_bib25","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/neuonc\/not121","article-title":"Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients","volume":"15","author":"Macdonald","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijrobp.2015.05.018","article-title":"Imaging changes in pediatric intracranial ependymoma patients treated with proton beam radiation therapy compared to intensity modulated radiation therapy","volume":"93","author":"Gunther","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2016.10.013_bib27","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3174\/ajnr.A4333","article-title":"Radiation necrosis in pediatric patients with brain tumors treated with proton radiotherapy","volume":"36","author":"Kralik","year":"2015","journal-title":"AJNR Am J Neuradiol"},{"key":"10.1016\/j.ejca.2016.10.013_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000028683","article-title":"Treatment of intracranial ependymoma by surgery alone","volume":"29","author":"Hukin","year":"1998","journal-title":"Pediatr Neurosurg"},{"key":"10.1016\/j.ejca.2016.10.013_bib29","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.ijrobp.2008.09.051","article-title":"Intracranial ependymomas in children: society of pediatric oncology experience with postoperative hyperfractionated local radiotherapy","volume":"74","author":"Conter","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2016.10.013_bib30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00381-009-1067-4","article-title":"Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis","volume":"26","author":"Zacharoulis","year":"2010","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ejca.2016.10.013_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.radonc.2015.07.023","article-title":"Use of proton therapy for re-irradiation in pediatric intracranial ependymoma","volume":"116","author":"Eaton","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijrobp.2007.09.037","article-title":"A retrospective study of surgery and reirradiation for recurrent ependymoma","volume":"71","author":"Merchant","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2016.10.013_bib33","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ijrobp.2011.10.039","article-title":"Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation","volume":"83","author":"Bouffet","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2016.10.013_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1096-911X(199607)27:1<8::AID-MPO3>3.0.CO;2-K","article-title":"Adjuvant chemotherapy of childhood posterior fossa ependymoma: craniospinal irradiation with or without adjuvant CCNU, vincristine and prednisone. A Children's Cancer group Study","volume":"27","author":"Evans","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3171\/jns.1998.88.4.0695","article-title":"Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group","volume":"88","author":"Robertson","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2016.10.013_bib36","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1470-2045(07)70208-5","article-title":"Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG\/SIOP prospective study","volume":"8","author":"Grundy","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib37","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.2001.19.5.1288","article-title":"Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors","volume":"19","author":"Grill","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000028654","article-title":"Prognostic factors in infants and very young children with intracranial ependymomas","volume":"28","author":"Duffner","year":"1998","journal-title":"Pediatr Neurosurg"},{"key":"10.1016\/j.ejca.2016.10.013_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11060-013-1111-9","article-title":"Outcome of infants and young children with newly diagnosed ependymoma treated on the \u201cHead Start\u201d III prospective clinical trial","volume":"113","author":"Venkatramani","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib40","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/00006123-199704000-00042","article-title":"Second-look surgery for incompletely resected fourth ventricle ependymomas: technical case report","volume":"40","author":"Foreman","year":"1997","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejca.2016.10.013_bib41","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/pbc.24274","article-title":"Phase II study of pre- irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology Group","volume":"59","author":"Garvin","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejca.2016.10.013_bib42","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1200\/JCO.2009.25.9119","article-title":"Phase I trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study","volume":"28","author":"Fouladi","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11060-015-1764-7","article-title":"An open-label, two- stage phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)","volume":"123","author":"DeWire","year":"2015","journal-title":"J Neuroncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11060-016-2155-4","article-title":"Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study","volume":"129","author":"Jakacki","year":"2016","journal-title":"J Neuroncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib45","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/neuonc\/nov181","article-title":"Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma","volume":"17","author":"Wright","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib46","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.bjc.6600180","article-title":"Genetic abnormalities detected in ependymomas by comparative genomic hybridization","volume":"86","author":"Carter","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2016.10.013_bib47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.canlet.2007.11.021","article-title":"Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma","volume":"261","author":"Pezzolo","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2016.10.013_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-4608(00)00218-1","article-title":"Gains and losses of DNA sequences in childhood brain tumors analyzed by comparative genomic hybridization","volume":"121","author":"Shlomit","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.ejca.2016.10.013_bib49","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/01.MP.0000087420.34166.B6","article-title":"Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors","volume":"16","author":"Zamecnik","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2016.10.013_bib50","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nature09173","article-title":"Cross- species genomics matches driver mutations and cell compartments to model ependymoma","volume":"466","author":"Johnson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2016.10.013_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ccr.2005.09.001","article-title":"Radial glia cells are candidate stem cells of ependymoma","volume":"8","author":"Taylor","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2016.10.013_bib52","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0002-9440(10)64491-4","article-title":"Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups","volume":"161","author":"Dyer","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejca.2016.10.013_bib53","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2009.27.3359","article-title":"Molecular staging of intracranial ependymoma in children and adults","volume":"28","author":"Korshunov","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.10.013_bib54","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature13108","article-title":"Epigenomic alterations define lethal CIMP-positive ependymomas of infancy","volume":"506","author":"Mack","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2016.10.013_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2011.07.007","article-title":"Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma","volume":"20","author":"Witt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2016.10.013_bib56","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature13109","article-title":"C11orf95-RELA fusions drive oncogenic NF-\u03baB signalling in ependymoma","volume":"506","author":"Parker","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2016.10.013_bib57","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","article-title":"Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups","volume":"27","author":"Pajtler","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2016.10.013_bib58","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1200\/JCO.2015.65.7825","article-title":"Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis","volume":"34","author":"Ramaswamy","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916324972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916324972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T11:54:19Z","timestamp":1536234859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804916324972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":58,"alternative-id":["S0959804916324972"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2016.10.013","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current therapy and the evolving molecular landscape of paediatric ependymoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2016.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}